Effectiveness and safety of bedaquiline-based, modified all-oral 9–11-month treatment regimen for rifampicin-resistant tuberculosis in Vietnam

OBJECTIVES: World Health Organization recommends a 7-drug 9–11-month rifampicin-resistant tuberculosis (RR-TB) short treatment regimen (STR). To reduce the pill burden, we assessed the safety and effectiveness of a 5-drug 9–11-month modified STR (mSTR). METHODS: Prospective cohort study of an all-or...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Thi Mai Phuong, Le, Thi Hai Minh, Merle, Corinne Simone Collette, Pedrazzoli, Debora, Nguyen, Nhat Linh, Decroo, Tom, Nguyen, Binh Hoa, Hoang, Thi Thanh Thuy, Nguyen, Viet Nhung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9789925/
https://www.ncbi.nlm.nih.gov/pubmed/36372364
http://dx.doi.org/10.1016/j.ijid.2022.11.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9789925/
https://www.ncbi.nlm.nih.gov/pubmed/36372364
http://dx.doi.org/10.1016/j.ijid.2022.11.007

Ejemplares similares